Oxford Nanopore Technologies

Oxford Nanopore Technologies is proud to collaborate with the ELRIN consortium to explore the potential of Oxford Nanopore sequencing as a first-line diagnostic tool for #rarediseases and familial #cancers. The European Long Read Innovation Network (ELRIN)—a pioneering initiative led by the University Tübingen and experts across Europe — aims to advance whole genome Oxford #Nanopore sequencing (#WGS) for potential clinical diagnostics, addressing significant unmet healthcare needs. With 21 labs across 11 countries, ELRIN will help establish best practices, generate reference datasets, and assess the feasibility of Oxford Nanopore sequencing in routine clinical testing. Why is this important? We highlight this on #RareDiseaseDay2025 because... -Up to 50% of #raredisease patients remain undiagnosed with current sequencing methods—impacting millions of lives globally. -Early & complex cancer syndromes remain unsolved, highlighting the need for new approaches in genomic medicine. Read more: https://lnkd.in/ejEYDnX2 #Genomics #RareDisease #PrecisionMedicine #RareDiseaseDay

Rapid sequencing meets real-time response – critical insights from the 2025 Sudan ebolavirus outbreak in Uganda. What does a world-class genomic response look like? When a healthcare worker in Kampala presented with symptoms in January, Uganda’s scientists moved fast. Within days, full genome data for Sudan ebolavirus was generated on site—even before lab confirmation. A remarkable achievement. https://lnkd.in/e9EgEXuA Using a field-ready nanopore sequencing protocol, the Uganda Virus Research Institute team identified the virus, traced its evolutionary origins, and confirmed its link to earlier outbreaks—all in near real time. As Peter van Heusden (SANBI) put it: “What we and our colleagues in Uganda managed – and I think it’s a genomic world speed record of sorts – was in part down to the technology, but it was also the readiness.” https://lnkd.in/encw85SW This wasn’t just a proof-of-concept. It was a demonstration of how world-class standards of care and surveillance can be delivered—with the right infrastructure, local expertise, and collaborative preparedness. Uganda and South Africa just showed the world how it’s done. The switch is ON.

Join our symposium at #ESCMID Global to explore how leading experts are harnessing real-time Oxford Nanopore sequencing to transform the clinical microbiology and public health landscape. Stop by booth B52 to be a part of our demos. Get the opportunity to load a flow cell, learn about the Nanopore-Only Microbial Sequencing Solution, and see how #ElysION provides streamlined sample-to-answer workflows. Plus, connect with fellow researchers and the Oxford Nanopore team to get your questions answered and hear the latest in infectious disease and microbiology innovation. Find out more here: https://bit.ly/4iZAOpe

Guess what? We’re back with our monthly publication picks! In this latest series we explore topics from cancer research, to gene therapy, to genome sequencing in the classroom, with these studies showcasing the advances in scientific research made possible by Oxford Nanopore sequencing. Click here to find out what you’re missing: https://bit.ly/41Tybyy

Great to see INMEGEN strengthen Mexico’s national genomics capacity with the installation of #PromethION 2 Solo— expanding their capabilities across research areas, including oncology, rare diseases, and infectious diseases — enabling faster, scalable, and more accessible #genomic insights. Read more here: https://lnkd.in/eNS6NgE6

#Tuberculosis is the deadliest infectious disease globally and a major contributor to antimicrobial resistance. On #WorldTBDay, it is important to highlight ongoing initiatives like this one in partnership with bioMérieux, which are advancing the ability to understand drug-resistant TB with the aim of improving public health worldwide.

The diversity and complexity of rare disease variants make data analysis challenging. In this knowledge exchange, learn how Oxford Nanopore Technologies #EPI2ME software provides a powerful platform to deliver streamlined analysis and reporting of all variant types behind rare disease. Sign up for the webinar here: https://bit.ly/4hBiykR

🚀 Announcing a Keynote Session at the 2025 BioHackathon featuring Dr. Lakmal Jayasinghe, CSO of Oxford Nanopore Technologies! Oxford Nanopore is revolutionizing DNA sequencing with its portable, real-time sequencing technology, making genomics more accessible and scalable. Join us for an exclusive Keynote Session, "Disruptive Innovation and the 4th Industrial Revolution: Oxford Nanopore– an Overnight Success 20 Years in the Making." 📅🚀 When: March 22, 2025 | 2PM-3PM UTC Join the BioHackathon to network with iGEMers, validate your ideas and explore new opportunities! 👉 Apply before March 17, 2025.: bit.ly/BioHackathon25 #igem #igemstartups #synbio #biofounders

Join this Knowledge Exchange to learn how Oxford Nanopore sequencing provides rapid and comprehensive metagenomic analysis. Discover how long #nanopore reads, combined with powerful bioinformatic tools, enable accurate taxonomic classification and antimicrobial resistance gene identification faster than alternative sequencing methods. Don’t miss out on how this has significant advantages in pathogen surveillance to enhance outbreak control. Find out more here: https://bit.ly/4ioiXbC

With only two months to go until London Calling 2025, don’t miss this opportunity to be a part of the biggest Oxford Nanopore sequencing event of the year. Hear the latest research from experts pioneering new possibilities across applications such as cancer, microbiology, human genetics and more. With more speakers to be announced, check out our agenda and get your ticket here: https://bit.ly/4iPwY1O